Lenvatinib (E7080)

Min.Order / FOB Price:Get Latest Price

1 Gram	FOB Price: USD 65.0000

1 Gram

FOB Price: USD 65.0000

Min.Order :1 Gram
Purity: 99%
Payment Terms : T/T,Other

Keywords

Lenvatinib (E7080) 417716-92-8 99%

Quick Details

Appearance:powder
Application:intermediate
PackAge:according to your need for packing
ProductionCapacity:1|Metric Ton|Day
Storage:dry
Transportation:sea,air,courier

Superiority:

Lenvatinib Usage And Synthesis
Thyroid cancer drugs Lenvatinib is a thyroid cancer drug developed by Eisai Corporation of Japan (Code: E7080), belonging to the inhibitor of oral multi-receptor tyrosine kinase (RTK) and can inhibit the kinase activity of the vascular endothelial growth factor (VEGF) Receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib can also inhibit the involvement of other RTKs in pathological angiogenesis, tumor growth, and cancer progression except for their normal cellular functions including fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4; platelet-derived growth factor receptor (PDGFR [alpha]), KIT, and RET.
[Indications]: Lenvatinib is suitable for the treatment of patients of thyroid cancer of local recurrence or metastasis type, progressivity type and radioactive iodine-refractory differentiated type.

Details:

Lenvatinib Basic information
Thyroid cancer drugs Biological activity In vitro study In vivo studies Feature
Product Name:   Lenvatinib
Synonyms:   4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide;E7080;LENVATINIB;E7080 (Lenvatinib);Lenvatinib (E7080);ER-203492-00;1-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea;4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide XEN445
CAS:   417716-92-8
MF:   C21H19ClN4O4
MW:   426.85
EINECS:   1592732-453-0
Mol File:   417716-92-8.mol

Lenvatinib Chemical Properties
Boiling point    627.2±55.0 °C(Predicted)
density    1.46
pka   13.09±0.70(Predicted)
CAS DataBase Reference   417716-92-8

View All